Gimoti denied for missing prior authorization by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for gimoti are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Requires Prior Authorization for Gimoti

BCBS, like most major insurers, places Gimoti (metoclopramide nasal spray) on a prior-authorization list because it is a branded specialty drug for a condition that also has lower-cost treatment options. Prior authorization (PA) is a pre-approval process: the plan reviews whether the request meets its coverage criteria before paying. A denial at this stage means either (a) a PA was not submitted before the prescription was filled, or (b) a PA was submitted but the plan concluded the criteria were not met.

## Why This Denial Is Appealable

A PA denial is not a final answer. The plan must tell you which specific criteria were not satisfied and give you a meaningful opportunity to appeal. If your prescriber has the clinical documentation to satisfy those criteria, the appeal can succeed. If the denial was procedural — the PA was not submitted in advance because the requirement was unknown — many plans will process a retroactive PA with supporting documentation.

## Your Federal Appeal Rights

• Expedited PA reconsideration: If you have an urgent clinical need, contact BCBS immediately to request an expedited determination (typically 72 hours or less).
• Internal appeal (ERISA §503 / ACA §2719): You may appeal any PA denial in writing within the deadline shown on the denial notice. The plan must provide a full and fair review, including review by a clinical peer.
• External review (ACA §2719): After exhausting internal appeals, you may request independent external review. The external reviewer is not employed by BCBS and can overturn the PA denial if the clinical record supports it. Standard external review closes within 45 days.
• State insurance department: If you believe BCBS is not following its own PA process or is applying criteria inconsistently, you may file a complaint with your state's insurance commissioner.

## Documentation to Gather

• PA denial letter: Obtain the exact list of unmet criteria from the denial notice — this is your roadmap.
• Diagnosis and severity: Gastric-emptying study results, treating physician's clinical notes documenting symptom severity and functional impact.
• Step-therapy compliance: Records showing any required prior therapies were tried, with dates, prescriptions, and documented outcomes.
• Prescriber medical-necessity letter: A detailed letter addressing each criterion the plan cited as unmet, cross-referenced to chart entries with dates.
• FDA prescribing information: The approved label documents the clinical basis for the nasal-spray formulation and the intended patient population.

## Criteria-Mapping Structure

Request the full PA criteria from BCBS (these are usually embedded in the PA denial letter or available in the plan's published coverage policy). Then:

| PA Criterion (from denial letter) | Satisfying Document and Chart Reference | |---|---| | [Each listed unmet criterion] | [Specific dated chart note, test result, or prescriber statement] |

Your prescriber's office can often resolve a PA denial more quickly by calling the plan's clinical review line directly and providing the documentation verbally before submitting the written appeal — but always follow up with a written record.